The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
- PMID: 10808163
- DOI: 10.1067/mai.2000.106485
The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
Abstract
Mast cells are of hematopoietic origin but typically complete their maturation in peripheral connective tissues, especially those near epithelial surfaces. Mast cells express receptors that bind IgE antibodies with high affinity (FcepsilonRI), and aggregation of these FcepsilonRI by the reaction of cell-bound IgE with specific antigens induces mast cells to secrete a broad spectrum of biologically active preformed or lipid mediators, as well as many cytokines. Mast cells are widely thought to be essential for the expression of acute allergic reactions, but the importance of mast cells in late-phase reactions and chronic allergic inflammation has remained controversial. Although it is clear that many cell types may be involved in the expression of late-phase reactions and chronic allergic inflammation, studies in genetically mast cell-deficient and congenic normal mice indicate that mast cells may be critical for the full expression of certain features of late-phase reactions and may also contribute importantly to clinically relevant aspects of chronic allergic inflammation. Moreover, the pattern of cytokines that can be produced by mast cell populations, and the enhancement of such cytokine production in mast cells that have undergone IgE-dependent up-regulation of their surface expression of FcepsilonRI, suggests that mast cells may contribute to allergic diseases (and host defense) by acting as immunoregulatory cells, as well as by providing effector cell function.
Similar articles
-
Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses.Curr Opin Immunol. 2006 Dec;18(6):751-60. doi: 10.1016/j.coi.2006.09.011. Epub 2006 Oct 2. Curr Opin Immunol. 2006. PMID: 17011762 Review.
-
The role of the FcepsilonRI beta-chain in allergic diseases.Int Arch Allergy Immunol. 2004 Sep;135(1):62-72. doi: 10.1159/000080231. Epub 2004 Aug 13. Int Arch Allergy Immunol. 2004. PMID: 15316148 Review.
-
Attainments in atop: special aspects of allergy and IgE.Adv Pediatr. 2002;49:273-97. Adv Pediatr. 2002. PMID: 12214775 Review.
-
The mast cell: a multifunctional effector cell.Adv Clin Path. 2003 Jan;7(1):13-26. Adv Clin Path. 2003. PMID: 19774733 Review.
-
Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells.Immunity. 2005 Aug;23(2):191-202. doi: 10.1016/j.immuni.2005.06.011. Immunity. 2005. PMID: 16111637
Cited by
-
PGD2 deficiency exacerbates food antigen-induced mast cell hyperplasia.Nat Commun. 2015 Jul 10;6:7514. doi: 10.1038/ncomms8514. Nat Commun. 2015. PMID: 26159556
-
Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing.J Exp Med. 2001 Nov 5;194(9):1243-52. doi: 10.1084/jem.194.9.1243. J Exp Med. 2001. PMID: 11696590 Free PMC article.
-
Mast cell function is not altered by Coronin-1A deficiency.J Leukoc Biol. 2010 Oct;88(4):737-45. doi: 10.1189/jlb.0310131. Epub 2010 Jul 19. J Leukoc Biol. 2010. PMID: 20643816 Free PMC article.
-
The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.Br J Pharmacol. 2009 Sep;158(1):267-76. doi: 10.1111/j.1476-5381.2009.00178.x. Epub 2009 Apr 9. Br J Pharmacol. 2009. PMID: 19371332 Free PMC article.
-
PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability.Blood. 2011 Nov 17;118(20):5466-75. doi: 10.1182/blood-2010-09-309955. Epub 2011 Sep 16. Blood. 2011. PMID: 21926349 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources